Seyeon Jeon, Ha Ra Jun, Ji-Young Lee, Chang Ohk Sung, Sung-Min Chun
{"title":"研究mirna驱动的DNA甲基化:基因特异性调节的统计证据。","authors":"Seyeon Jeon, Ha Ra Jun, Ji-Young Lee, Chang Ohk Sung, Sung-Min Chun","doi":"10.1177/00368504251370988","DOIUrl":null,"url":null,"abstract":"<p><p>ObjectiveDNA methylation is a key regulator of gene expression and plays a crucial role in cancer development. However, the mechanisms driving gene-specific methylation remain unclear. This study investigates the role of microRNAs (miRNAs) in regulating promoter methylation of specific genes, aiming to uncover miRNA-driven modulation of gene methylation in cancer.MethodsWe analyzed data from the Cancer Cell Line Encyclopedia (CCLE) database, comprising 813 cell lines. Spearman's rank correlation was performed between the expression levels of 734 miRNAs and the methylation levels of 20,587 genes, focusing on CpG islands in promoter regions. Linear regression analysis was used to validate the relationship between selected miRNAs and gene clusters. Bioinformatics screening identified statistically significant miRNA-gene pairs involved in promoter methylation.ResultsThe analysis revealed 25 target genes whose promoter methylation was significantly associated with the expression of four miRNAs (hsa-miR-200a, hsa-miR-200b, hsa-miR-200c, and hsa-miR-141). These correlations were most pronounced in colorectal, gastric, lung, and ovarian cancers. Notably, cancer-related genes such as ST14, OVOL1, and EPCAM were identified as targets, supporting the hypothesis that miRNAs regulate promoter methylation in these genes.ConclusionOur findings suggest that specific miRNAs induce promoter methylation in cancer-related genes, thereby influencing gene expression. This study expands our understanding of the role of miRNAs in tumor development and highlights the potential of miRNA-based therapies in cancer treatment. As this is a computational study, further experimental validation is required to confirm the proposed regulatory mechanisms.</p>","PeriodicalId":56061,"journal":{"name":"Science Progress","volume":"108 3","pages":"368504251370988"},"PeriodicalIF":2.9000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12365458/pdf/","citationCount":"0","resultStr":"{\"title\":\"Investigating miRNA-driven DNA methylation: Statistical evidence of gene-specific modulation.\",\"authors\":\"Seyeon Jeon, Ha Ra Jun, Ji-Young Lee, Chang Ohk Sung, Sung-Min Chun\",\"doi\":\"10.1177/00368504251370988\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>ObjectiveDNA methylation is a key regulator of gene expression and plays a crucial role in cancer development. However, the mechanisms driving gene-specific methylation remain unclear. This study investigates the role of microRNAs (miRNAs) in regulating promoter methylation of specific genes, aiming to uncover miRNA-driven modulation of gene methylation in cancer.MethodsWe analyzed data from the Cancer Cell Line Encyclopedia (CCLE) database, comprising 813 cell lines. Spearman's rank correlation was performed between the expression levels of 734 miRNAs and the methylation levels of 20,587 genes, focusing on CpG islands in promoter regions. Linear regression analysis was used to validate the relationship between selected miRNAs and gene clusters. Bioinformatics screening identified statistically significant miRNA-gene pairs involved in promoter methylation.ResultsThe analysis revealed 25 target genes whose promoter methylation was significantly associated with the expression of four miRNAs (hsa-miR-200a, hsa-miR-200b, hsa-miR-200c, and hsa-miR-141). These correlations were most pronounced in colorectal, gastric, lung, and ovarian cancers. Notably, cancer-related genes such as ST14, OVOL1, and EPCAM were identified as targets, supporting the hypothesis that miRNAs regulate promoter methylation in these genes.ConclusionOur findings suggest that specific miRNAs induce promoter methylation in cancer-related genes, thereby influencing gene expression. This study expands our understanding of the role of miRNAs in tumor development and highlights the potential of miRNA-based therapies in cancer treatment. As this is a computational study, further experimental validation is required to confirm the proposed regulatory mechanisms.</p>\",\"PeriodicalId\":56061,\"journal\":{\"name\":\"Science Progress\",\"volume\":\"108 3\",\"pages\":\"368504251370988\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12365458/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Science Progress\",\"FirstCategoryId\":\"103\",\"ListUrlMain\":\"https://doi.org/10.1177/00368504251370988\",\"RegionNum\":4,\"RegionCategory\":\"综合性期刊\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/19 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"MULTIDISCIPLINARY SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science Progress","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.1177/00368504251370988","RegionNum":4,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/19 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
摘要
目的dna甲基化是基因表达的关键调控因子,在肿瘤的发生发展中起着至关重要的作用。然而,驱动基因特异性甲基化的机制仍不清楚。本研究探讨了microRNAs (miRNAs)在调节特定基因启动子甲基化中的作用,旨在揭示mirna驱动的癌症基因甲基化调节。方法我们分析了来自Cancer Cell Line Encyclopedia (CCLE)数据库的数据,其中包括813个细胞系。在734个mirna的表达水平与20587个基因的甲基化水平之间进行Spearman秩相关,重点关注启动子区域的CpG岛。采用线性回归分析验证所选mirna与基因簇之间的关系。生物信息学筛选鉴定了具有统计学意义的mirna -基因对参与启动子甲基化。结果分析发现25个靶基因,其启动子甲基化与四种mirna (hsa-miR-200a、hsa-miR-200b、hsa-miR-200c和hsa-miR-141)的表达显著相关。这些相关性在结直肠癌、胃癌、肺癌和卵巢癌中最为明显。值得注意的是,癌症相关基因如ST14、OVOL1和EPCAM被确定为靶标,这支持了mirna调节这些基因启动子甲基化的假设。结论我们的研究结果表明,特异性mirna诱导癌症相关基因的启动子甲基化,从而影响基因表达。这项研究扩大了我们对mirna在肿瘤发展中的作用的理解,并强调了基于mirna的治疗在癌症治疗中的潜力。由于这是一项计算研究,需要进一步的实验验证来确认所提出的调节机制。
Investigating miRNA-driven DNA methylation: Statistical evidence of gene-specific modulation.
ObjectiveDNA methylation is a key regulator of gene expression and plays a crucial role in cancer development. However, the mechanisms driving gene-specific methylation remain unclear. This study investigates the role of microRNAs (miRNAs) in regulating promoter methylation of specific genes, aiming to uncover miRNA-driven modulation of gene methylation in cancer.MethodsWe analyzed data from the Cancer Cell Line Encyclopedia (CCLE) database, comprising 813 cell lines. Spearman's rank correlation was performed between the expression levels of 734 miRNAs and the methylation levels of 20,587 genes, focusing on CpG islands in promoter regions. Linear regression analysis was used to validate the relationship between selected miRNAs and gene clusters. Bioinformatics screening identified statistically significant miRNA-gene pairs involved in promoter methylation.ResultsThe analysis revealed 25 target genes whose promoter methylation was significantly associated with the expression of four miRNAs (hsa-miR-200a, hsa-miR-200b, hsa-miR-200c, and hsa-miR-141). These correlations were most pronounced in colorectal, gastric, lung, and ovarian cancers. Notably, cancer-related genes such as ST14, OVOL1, and EPCAM were identified as targets, supporting the hypothesis that miRNAs regulate promoter methylation in these genes.ConclusionOur findings suggest that specific miRNAs induce promoter methylation in cancer-related genes, thereby influencing gene expression. This study expands our understanding of the role of miRNAs in tumor development and highlights the potential of miRNA-based therapies in cancer treatment. As this is a computational study, further experimental validation is required to confirm the proposed regulatory mechanisms.
期刊介绍:
Science Progress has for over 100 years been a highly regarded review publication in science, technology and medicine. Its objective is to excite the readers'' interest in areas with which they may not be fully familiar but which could facilitate their interest, or even activity, in a cognate field.